{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T17:12:53Z","timestamp":1780593173780,"version":"3.54.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Myeloproliferative neoplasms are a group of diseases with diverse biological and clinical characteristics. As a provisional separate entity, myeloid\/lymphoid neoplasms with eosinophilia and genetic rearrangement have been described, which may present an initial clinical behavior of myeloproliferation and be characterized by varied genetic rearrangements. One of these entities is associated with FGFR1 rearrangements, characterized by its low prevalence and few treatment options.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present the case of a 53-year-old Mestizo male patient of Hispanic origin who initially presented weight loss and fatigue, with a complete blood count showing leukocytosis and eosinophilia, with an initial diagnosis of nonspecific myeloproliferative disorder. In a next-generation sequencing study, BCR::FGFR1 rearrangement was documented, a diagnosis of myeloid\/lymphoid neoplasia with eosinophilia and BCR::FGFR1 rearrangement was made, and hydroxyurea therapy was initiated. Subsequently, transformation to cortical T-lymphoblastic leukemia\/lymphoma and erythroid precursors was documented, requiring management with chemotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Myeloid\/lymphoid neoplasms with eosinophilia and genetic rearrangements constitute a group of deeply heterogeneous diseases with variable clinical and diagnostic characteristics and whose treatment is not clearly defined.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-022-03722-y","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T01:02:43Z","timestamp":1674694963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Myeloid\/lymphoid neoplasm with eosinophilia and BCR\/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2340-2953","authenticated-orcid":false,"given":"Alejandro Pineda","family":"Isaza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago Casta\u00f1o","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisceth Paola Quintero","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabi\u00e1n Emiliano Ahumada","family":"C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Felipe Arbel\u00e1ez","family":"Olivar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos Bravo","family":"Oca\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"3722_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1056\/NEJMra1406186","volume":"376","author":"J Spivak","year":"2017","unstructured":"Spivak J. Myeloproliferative neoplasms. N Engl J Med. 2017;376:2168\u201381.","journal-title":"N Engl J Med"},{"key":"3722_CR2","unstructured":"Vardiman J. Myeloproliferative Neoplasm. En: Jaffe E et\u00a0al. Hematopathology 2d Ed. Elsevier, 2017."},{"key":"3722_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100706","volume":"42","author":"R Shallis","year":"2020","unstructured":"Shallis R, et\u00a0al. Epidemiology of the classical myeloproliferative neoplasms: the four corners of an expansive and complex map. Blood Rev. 2020;42: 100706.","journal-title":"Blood Rev"},{"issue":"7","key":"3722_CR4","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1080\/10428194.2017.1397663","volume":"59","author":"P Strati","year":"2018","unstructured":"Strati P, et\u00a0al. Myeloid\/lymphoid neoplasms with FGFR1 rearrangement. Leuk Lymphoma. 2018;59(7):1672\u20136.","journal-title":"Leuk Lymphoma"},{"key":"3722_CR5","unstructured":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. 2016; Ch 11."},{"key":"3722_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.clml.2022.03.008","volume":"22","author":"A Kim","year":"2022","unstructured":"Kim A, Pozdnyakova A. State of the art updates and next questions. Myeloid\/lymphoid neoplasms with eosinophilia and gene rearrangements: diagnostic pearls and pitfalls. Clin Lymph Myel Leuk. 2022;22:643.","journal-title":"Clin Lymph Myel Leuk."},{"key":"3722_CR7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.137695","volume":"101","author":"H Qin","year":"2016","unstructured":"Qin H, Wu Q, Cowell J, Ren M. FGFR1OP2-FGFR1 induced myeloid leukemia and T-cell lymphoma in a mouse model. Haematologica. 2016;101: e93.","journal-title":"Haematologica"},{"key":"3722_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.humpath.2017.05.008","volume":"65","author":"X Montenegro-Garreaud","year":"2017","unstructured":"Montenegro-Garreaud X, et\u00a0al. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)\/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast pase. Human Pathol. 2017;65:147\u201356.","journal-title":"Human Pathol"},{"key":"3722_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4103\/IJPM.IJPM_357_17","volume":"60","author":"G Gopan","year":"2017","unstructured":"Gopan G, Anoop TM, Prakash NP, Nambiar R, Krishnachandran R. Fibroblast growth factor receptor-1 associated myeloproliferative neoplasm and T-lymphoblastic lymphoma. Indian J Pathol Microbiol. 2017;60:593\u20135.","journal-title":"Indian J Pathol Microbiol"},{"issue":"10","key":"3722_CR10","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/ajh.25617","volume":"94","author":"W Shomali","year":"2019","unstructured":"Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019;94(10):1149\u201367.","journal-title":"Am J Hematol"},{"key":"3722_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41409-021-01553-x","volume":"57","author":"J Hern\u00e1ndez-Boluda","year":"2022","unstructured":"Hern\u00e1ndez-Boluda J, et\u00a0al. Allogeneic hematopoietic cell transplantation in patients with myeloid\/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplant. 2022;57:416\u201322.","journal-title":"Bone Marrow Transplant"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03722-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-022-03722-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-022-03722-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T01:03:12Z","timestamp":1674694992000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-022-03722-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3722"],"URL":"https:\/\/doi.org\/10.1186\/s13256-022-03722-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"assertion":[{"value":"18 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The contents of this manuscript are in accordance with the Declaration of Helsinki for Ethics. No committee approval was available since this is a patient of our private clinic network. Written informed consent to participate has been acquired from the patient himself and is available upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}